Passage BIO, Inc. Common Stock Shares Outstanding

Quick Answer

Passage BIO, Inc. reported Common Stock Shares Outstanding of 3.18 million shares for the year ending 2025.

  • Passage BIO, Inc. showed an increase of +0.7% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Passage BIO, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Passage BIO, Inc.'s Common Stock Shares Outstanding has declined by 25.9%.
  • Historical annual values: Fiscal year 2025: 3.18 million shares | Fiscal year 2024: 3.16 million shares | Fiscal year 2023: 54.94 million shares | Fiscal year 2022: 54.61 million shares | Fiscal year 2021: 54.24 million shares | Fiscal year 2020: 45.61 million shares | Fiscal year 2019: 4.29 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: